Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Allen

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH TrialOlive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Global Pediatric Health|July 7, 2017
Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, MalawiNader Kim El-Mallawany, Mercy Mutai, Idah Mtete, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
The Journal of Experimental Medicine|March 19, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Frontiers in Immunology|December 28, 2020
Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of MortalityJacqueline D Squire, Stephanie N Vazquez, Angela Chan, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Acute liver failure and unique challenges of pediatric liver transplantation amidst a worldwide cluster of adenovirus-associated hepatitisAnna M Banc-Husu, Elizabeth A Moulton, Henry Shiau, et al.
Cancers|December 5, 2020
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin LymphomaJennifer E Agrusa, Brooks P Scull, Harshal A Abhyankar, et al.
Blood Advances|January 15, 2026
Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cellsJennifer E Agrusa, Elmoataz Abdel Fattah, Howard Lin, et al.
The Journal of Experimental Medicine|February 4, 2015
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH TrialOlive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Global Pediatric Health|July 7, 2017
Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, MalawiNader Kim El-Mallawany, Mercy Mutai, Idah Mtete, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
The Journal of Experimental Medicine|March 19, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Frontiers in Immunology|December 28, 2020
Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of MortalityJacqueline D Squire, Stephanie N Vazquez, Angela Chan, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Acute liver failure and unique challenges of pediatric liver transplantation amidst a worldwide cluster of adenovirus-associated hepatitisAnna M Banc-Husu, Elizabeth A Moulton, Henry Shiau, et al.
Cancers|December 5, 2020
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin LymphomaJennifer E Agrusa, Brooks P Scull, Harshal A Abhyankar, et al.
Blood Advances|January 15, 2026
Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cellsJennifer E Agrusa, Elmoataz Abdel Fattah, Howard Lin, et al.
The Journal of Experimental Medicine|February 4, 2015
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Pageof 14